NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/23/2026
Back to search
Official data from USPTO
CLEARVIEW EYE AND LASER MEDICAL CENTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
08/11/2026
Trademark type
Combined
Nice classes
44
Filing date
10/29/2004
Registration date
05/23/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/23/2026
Last transaction
08/11/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/15/1997
First use in commerce
11/15/1997
Drawing code
5
Owner type
99
Owner location
San Diego, CA, US
Examiner
MACIOL II, EUGENE VALENTINE-JO
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ClearView Eye and Laser Medical Center, P.C.
ClearView Eye and Laser Medical Center, P.C.
Representatives
Lawrence H. Binderow, Attorney at Law BINDEROW LAW OFFICES
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Eye care servicesophthalmologyoptometry serviceslaser vision correction surgery
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/23/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/23/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/23/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/14/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/14/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/14/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
05/22/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/23/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/07/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/06/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/06/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/06/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
05/17/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/23/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/15/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/15/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/15/2012
E815
TEAS SECTION 8 & 15 RECEIVED
01/04/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2006
PUBO
PUBLISHED FOR OPPOSITION
02/28/2006
NPUB
NOTICE OF PUBLICATION
02/08/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/19/2006
ALIE
ASSIGNED TO LIE
01/13/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/20/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2005
PAPER RECEIVED
12/07/2005
CNRT
NON-FINAL ACTION MAILED
06/08/2005
CNRT
NON-FINAL ACTION WRITTEN
06/07/2005
DOCK
ASSIGNED TO EXAMINER
06/06/2005
NWAP
NEW APPLICATION ENTERED
11/06/2004
Continuous trademark protection
Get notified about every new filing that threatens CLEARVIEW EYE AND LASER MEDICAL CENTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.